Work

FP09.01 Mobocertinib in Platinum-Pretreated EGFR Exon 20 Insertion+ Metastatic NSCLC Patients With/Without Prior Anti-PD(L)-1 Therapy

Year: 2021

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2021.08.235

Authors: P. Janne, S. Ramalingam, T. Kim, J.C. Yang, G. Riely, T. Mekhail, D. Nguyen, M.R. García Campelo, E. Felip, S. Jin, C. Griffin, V. Bunn, J. Lin, M. Mehta, C. Zhou

Institutions: Dana-Farber Cancer Institute, Emory University, Seoul National University Hospital, National Taiwan University Hospital, Memorial Sloan Kettering Cancer Center, AdventHealth Orlando, Complexo Hospitalario Universitario A Coruña, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology, Takeda Oncology (United States), Shanghai Pulmonary Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3204989011

FWCI: 0.285

Cites:

Cited by: 2

Related to: 10